Near-infrared spectroscopy: Promising diagnostic tool for viral infections

Abstract Although several methods, including enzyme-linked immunosorbent assay, polymerase chain reaction, immunofluorescent assay, and Western blotting, have been used for the diagnosis of viral infections, none of them is ideal in terms of cost-effectiveness, speed, and accuracy. Currently, the rate of outbreak of emerging viruses is increasing and therefore the development and establishment of analytical methods for such viral infections are becoming more important. Near-infrared (NIR) spectroscopy is a fast, multicomponent assay that enables non-invasive, non-destructive analysis. Recently, the diagnosis of viral infections using NIR spectroscopy has been attempted. In this review, the potential of the NIR method in the medical and virological fields is discussed.

[1]  P. Mortimer,et al.  Prospects for the development of pre‐mortem laboratory diagnostic tests for Creutzfeldt‐Jakob disease , 2004, Reviews in medical virology.

[2]  E. Seifried,et al.  Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting , 1999, The Lancet.

[3]  B. Hjelle,et al.  Hantaviruses: a global disease problem. , 1997, Emerging infectious diseases.

[4]  R. Webster,et al.  A pandemic warning? , 1997, Nature.

[5]  T. Kuiken,et al.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease , 2001, Nature Medicine.

[6]  M. Germain,et al.  Estimates of risk of window-period transmission of blood-borne viral diseases in Quebec , 2004, Canadian Medical Association Journal.

[7]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[8]  Arnold Wexler,et al.  Humidity and moisture : measurement and control in science and industry , 1965 .

[9]  B. Osborne,et al.  Non-invasive Monitoring of Dough Mixing by Near Infrared Spectroscopy , 1998 .

[10]  F. Jöbsis.  Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. , 1977, Science.

[11]  Y. Ozaki,et al.  Surface plasmon resonance near-infrared spectroscopy. , 2004, Analytical chemistry.

[12]  G. Leparc,et al.  Window‐period human immunodeficiency virus transmission to two recipients by an adolescent blood donor , 2004, Transfusion.

[13]  B. Cant,et al.  Evaluation of a transcription‐mediated amplification‐based HCV and HIV‐1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system , 2003, Transfusion.

[14]  C. Rinaldi,et al.  Qualitative multiplex RT-PCR for simultaneous detection of hepatitis C virus and human immunodeficiency virus in plasma samples. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  O. Ottmann,et al.  Comparison of TaqMan real-time PCR and p24 Elisa for quantification of in vitro HIV-1 replication. , 2003, Journal of virological methods.

[16]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[17]  F. Brun-Vézinet,et al.  HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients , 1994, The Lancet.

[18]  S. Kleinman,et al.  The Risk of Transfusion-Transmitted Viral Infections , 1996 .

[19]  Tony McMichael,et al.  Human Frontiers, Environments and Disease: Past Patterns, Uncertain Futures , 2001 .

[20]  M. Barrett.  The fall and rise of sleeping sickness , 1999, The Lancet.

[21]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[22]  B. Horecker.  THE ABSORPTION SPECTRA OF HEMOGLOBIN AND ITS DERIVATIVES IN THE VISIBLE AND NEAR INFRA-RED REGIONS , 1943 .

[23]  J. Temple,et al.  Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. , 2004, Journal of virological methods.

[24]  B. Nosal,et al.  West Nile Virus , 2016, Methods in Molecular Biology.

[25]  S. Stramer,et al.  NAT of the United States and Canadian blood supply , 2000, Transfusion.

[26]  J. AuBuchon,et al.  The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations , 2003, Transfusion.

[27]  M E Woolhouse,et al.  Risk factors for human disease emergence. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[28]  A. Sakudo,et al.  A Novel Diagnostic Method for Human Immunodeficiency Virus Type‐1 in Plasma by Near‐Infrared Spectroscopy , 2005, Microbiology and immunology.

[29]  K. König,et al.  Multiphoton microscopy in life sciences , 2000, Journal of microscopy.

[30]  A. Hall,et al.  Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001 , 2003, Vox sanguinis.

[31]  F. Omaswa,et al.  An outbreak of Ebola in Uganda , 2002, Tropical medicine & international health : TM & IH.

[32]  H. Heise,et al.  Chemometrics in Near‐Infrared Spectroscopy , 2007 .

[33]  Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNA , 1999, Vox sanguinis.

[34]  C. Featherstone.  Escherichia coli O157: superbug or mere sensation? , 1997, The Lancet.

[35]  P. Friedl,et al.  Determination of recombinant protein in animal cell culture supernatant by near-infrared spectroscopy. , 1997, Analytical biochemistry.

[36]  Chief,et al.  Addressing emerging infectious disease threats: a prevention strategy for the United States. Executive summary. , 1994, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[37]  K. Norris,et al.  4. Direct Spectrophotometric Determination of Moisture Content of Grain and Seeds , 1996 .

[38]  H. Siesler,et al.  Near-infrared spectroscopy:principles,instruments,applications , 2002 .

[39]  Helen H. Lee,et al.  AIDS in an HIV‐seronegative Ghanaian woman with intersubtype A/G recombinant HIV‐1 infection , 2000, Journal of medical virology.

[40]  A. Flamand,et al.  Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence , 1988, Journal of virology.

[41]  C. Farrington,et al.  Deaths from variant Creutzfeldt-Jakob disease , 1999, The Lancet.

[42]  S. Kleinman,et al.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. , 1996, The New England journal of medicine.

[43]  J. Stoker,et al.  The Department of Health and Human Services. , 1999, Home healthcare nurse.

[44]  D. Marriott,et al.  False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in Thailand. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[45]  Tom Fearn,et al.  Practical Nir Spectroscopy With Applications in Food and Beverage Analysis , 1993 .